Piper Jaffray
Piper Jaffray is a client-focused, middle market investment bank and institutional securities firm founded in 1895 and based in Minneapolis, Minnesota.
Its Investment Banking activities include raising capital through equity and debt financings for corporate clients; providing financial advisory services relating to mergers and acquisitions to consumer, financial institutions, health care, technology, alternative energy, business services, and industrial growth sectors; underwriting debt issuances for government and non-profit clients; and providing financial advisory and interest rate risk management services.
The company's equity and fixed income institutional sales and trading activities include equity and fixed income advisory and trade execution services for public and private corporations, public entities, non-profit clients, and institutional investors.
View Older Stories View More Recent Stories
-
Notable 52-Week High's and Low's of the Day 06/22: BVF, SNWL, VRX, ARBA High; NOK, RAD, CYPB, URRE Low
-
Adobe (ADBE) Shares Mixed Ahead of Q2 Results Tonight
-
Notable Analyst Rating Changes 06/22: VRX, LNCR, MAT, ARBA Upgraded; BVF, BIG, WAG, NOV Downgraded
-
Piper Jaffray Starts Express (EXPR) at Overweight, $23 Price Target
-
Piper Jaffray Downgrades Biovail (BVF) to Neutral Following Merger Announcement
-
Piper Jaffray Upgrades Valeant Pharmaceuticals (VRX) to Overweight; Compelling Cash Flow Story with Addition of BVF
-
Piper Jaffray Comfortable With Q2 Estimates for Baidu.com (BIDU); New China Search Engine Topical, But Our Findings Suggest No Threat
-
Unusual 11 Mid-Day Movers 06/21: EFJI, AIPC, UTSI, MELA, RADA, BVF Higher; AFFY, CYPB, ZIOP, FORD, PCBC Lower
-
Morning Movers 6/21: EFJI, AIPC, GKK, RADA, BVF Higher; AFFY, ZIOP, UAHC, CYPB, CPKI Lower
-
Notable Analyst Rating Changes 06/21: PLD, TC, AMLN, PLCM Upgraded; AFFY, TMRK, MDAS, LAZ Downgraded
-
Piper Jaffray Downgrades Affymax (AFFY) to Underweight; Disappointing Hematide Profile
-
Piper Jaffray Reiterates an Overweight on EMC (EMC) Ahead of Q2 Results
-
Unusual 11 Mid-Day Movers 06/18: CWLZ, MIPI, PESI, AMLN, AIB, ENTR Higher; ADLR, BANR, WBD, IFLG, GMTC Lower
-
Roche's Taspoglutide Setback Gives Amylin (AMLN) A Boost
-
Morning Movers 6/18: CWLZ, NMTI, AMLN, ALKS Higher; GMTC, ADLR, BANR Lower
-
JPMorgan Raises Amylin (AMLN) to Overweight Following Taspo Delay
-
Amylin (AMLN) Jumps On Taspo Delay
-
Piper Jaffray Said Taspo Delays A Positive for Amylin (AMLN)
-
Piper Jaffray Keeps 'Neutral' Rating on DreamWorks Animation (DWA); Lowering Estimates, Likely For The Last Time
-
Higher One (ONE) IPO Surges Higher
-
Higher One (ONE) IPO Prices at $12, Well Below Expected Range
-
FedEx (FDX) Guidance Falls Below Street, Competiton Jumps on News (UPS, CHRW, EXPD, IYT)
-
Piper Jaffray Raises Estimates and Price Target on Apple (AAPL) Due to iPhone 4
-
Earnings Preview: FedEx (FDX) Looks To Deliver For Shareholders in Q4
-
Earnings Preview: Best Buy (BBY) Looks To Keep Momentum In Q1
-
Notable 52-Week High's and Low's of the Day 06/14: LVS, SNDK, JBLU, NFLX High; ULU, TRMA, ADG, AMPL Low
-
Shares of Archipelago Learning (ARCL) Fall to New 52-Wk Low; Piper Jaffray Downgrades as Core Business Visibility Dim
-
Piper Jaffray Raises Netflix (NFLX) Price Target to $140; Reiterates Overweight
-
Piper Jaffray Initiates Coverage on Alpha & Omega (AOSL) with an Overweight
-
Piper Jaffray I nitiates Coverage on Charm Communications (CHRM) with an Overweight; Leading China Ad Agency
-
Notable Analyst Rating Changes 06/14: CRNT, JBLU, AMLN, HIG Upgraded; AKAM, ISRG, DO, ARCL Downgraded
-
Daily State of the Markets 6/14: Is Something Missing?
-
Piper Jaffray Upgrades Amylin Pharmaceuticals (AMLN) to Overweight; Valuation and Best in Class Profile of Bydureon
-
Piper Jaffray Downgrades Archipelago Learning (ARCL) to Neutral; Core Business Visibility Dim & New Execution Risks
-
Piper Jaffray Initiates Coverage on Douglas Dynamics (PLOW) with an Overweight; Pent Up Demand Sets Stage For Solid Returns
-
Ulta Salon (ULTA) Prices 8.98M Common Offering at $22.25/Share
-
Wedbush, Piper Jaffray Preview Q1 Earnings at Best Buy (BBY); Stock Trading Higher Ahead of Tuesday's Report
-
Shares of Cepheid (CPHD) Get Boost From Piper Jaffray Upgrade
-
China New Borun (BORN) IPO Opens Higher After Slashing Price
-
Piper Jaffray Upgrades Cepheid (CPHD) to Overweight; Sell-Off Creates Opportunity
-
Piper Jaffray Maintains 'Overweight' Rating on LogMeIn (LOGM); Ignition for iPad Could Add 1-4% To FY10 & 11 Revs
-
China New Borun (BORN) Prices IPO at $7.00/ADS
-
FedEx (FDX) June option prices elevated into EPS and FX revenue outlook
-
Piper Jaffray Said All Eyes Will Be On FedEx (FDX) Guidance
-
Shares of Regeneron Pharmaceuticals (REGN) Continue to Slide for Fifth Straight Session; Piper Jaffray Recommends Buying on Weakness
-
Piper Jaffray Reiterates an 'Overweight' on Regeneron (REGN); More on Arcalyst in Gout; Buy on Weakness
-
Take-Two Interactive (TTWO) Opened Higher After Strong Q2 & Guidance Report; Shares Turn Negative as Several Firms Raise Comment
-
Piper Jaffray Still On the Sidelines With Talbots (TLB) After Q1 Results
-
Piper Jaffray Trims Estimates On McGraw-Hill (MHP), Maintains Overweight Rating
-
Piper Jaffray Ups Price Target On Two Take Interactive (TTWO) to $11, Maintains Neutral
